Mesecar

Dr. Andrew Mesecar is a prominent researcher specializing in biochemistry, structural biology, and cancer drug discovery. His key research features and contributions include:

Dr. Mesecar's team played a crucial role in identifying the antiviral X77 , which was effective against the SARS-CoV-2 main protease ( Mprocap M raised to the p r o power mesecar

), helping guide the development of treatments like . Mesecar's team played a crucial role in identifying

He specializes in determining high-resolution 3D structures of enzymes (such as 3CLpro and PLpro) in coronaviruses and cancer to design selective drugs. He is the Robert Wallace Miller Director of

He is involved in translational research to turn basic molecular findings into commercial drugs for cancer and Alzheimer's disease.

He is the Robert Wallace Miller Director of the Purdue Institute for Cancer Research , where he leads efforts in developing novel cancer therapies, diagnostics, and targeting cancer at the cellular level.